Global Intravitreal Injectable Market Growth 2022-2028
As the global economy mends, the 2021 growth of Intravitreal Injectable will have significant change from previous year. According to our latest study, the global Intravitreal Injectable market size is USD million in 2022 from USD 14210 million in 2021, with a change of % between 2021 and 2022. The global Intravitreal Injectable market size will reach USD 23380 million in 2028, growing at a CAGR of 7.4% over the analysis period.
The United States Intravitreal Injectable market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Intravitreal Injectable market, reaching US$ million by the year 2028. As for the Europe Intravitreal Injectable landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Intravitreal Injectable players cover Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, and Genentech, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Intravitreal Injectable market by product type, application, key manufacturers and key regions and countries.
Segmentation by drug: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Anti-VEGF
Steroids
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Macular Degeneration
Macular Edema
Uveitis
Retinal Vein Occlusion
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Regeneron Pharmaceuticals (Eylea)
Allergan
EyePoint Pharmaceuticals
Genentech
Kanghong Pharmaceutical
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Intravitreal Injectable Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Intravitreal Injectable by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Intravitreal Injectable by Country/Region, 2017, 2022 & 2028
2.2 Intravitreal Injectable Segment by Drug
2.2.1 Anti-VEGF
2.2.2 Steroids
2.2.3 Others
2.3 Intravitreal Injectable Sales by Drug
2.3.1 Global Intravitreal Injectable Sales Market Share by Drug (2017-2022)
2.3.2 Global Intravitreal Injectable Revenue and Market Share by Drug (2017-2022)
2.3.3 Global Intravitreal Injectable Sale Price by Drug (2017-2022)
2.4 Intravitreal Injectable Segment by Disease
2.4.1 Macular Degeneration
2.4.2 Macular Edema
2.4.3 Uveitis
2.4.4 Retinal Vein Occlusion
2.4.5 Others
2.5 Intravitreal Injectable Sales by Disease
2.5.1 Global Intravitreal Injectable Sale Market Share by Disease (2017-2022)
2.5.2 Global Intravitreal Injectable Revenue and Market Share by Disease (2017-2022)
2.5.3 Global Intravitreal Injectable Sale Price by Disease (2017-2022)
3 Global Intravitreal Injectable by Company
3.1 Global Intravitreal Injectable Breakdown Data by Company
3.1.1 Global Intravitreal Injectable Annual Sales by Company (2020-2022)
3.1.2 Global Intravitreal Injectable Sales Market Share by Company (2020-2022)
3.2 Global Intravitreal Injectable Annual Revenue by Company (2020-2022)
3.2.1 Global Intravitreal Injectable Revenue by Company (2020-2022)
3.2.2 Global Intravitreal Injectable Revenue Market Share by Company (2020-2022)
3.3 Global Intravitreal Injectable Sale Price by Company
3.4 Key Manufacturers Intravitreal Injectable Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intravitreal Injectable Product Location Distribution
3.4.2 Players Intravitreal Injectable Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Intravitreal Injectable by Geographic Region
4.1 World Historic Intravitreal Injectable Market Size by Geographic Region (2017-2022)
4.1.1 Global Intravitreal Injectable Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Intravitreal Injectable Annual Revenue by Geographic Region
4.2 World Historic Intravitreal Injectable Market Size by Country/Region (2017-2022)
4.2.1 Global Intravitreal Injectable Annual Sales by Country/Region (2017-2022)
4.2.2 Global Intravitreal Injectable Annual Revenue by Country/Region
4.3 Americas Intravitreal Injectable Sales Growth
4.4 APAC Intravitreal Injectable Sales Growth
4.5 Europe Intravitreal Injectable Sales Growth
4.6 Middle East & Africa Intravitreal Injectable Sales Growth
5 Americas
5.1 Americas Intravitreal Injectable Sales by Country
5.1.1 Americas Intravitreal Injectable Sales by Country (2017-2022)
5.1.2 Americas Intravitreal Injectable Revenue by Country (2017-2022)
5.2 Americas Intravitreal Injectable Sales by Drug
5.3 Americas Intravitreal Injectable Sales by Disease
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravitreal Injectable Sales by Region
6.1.1 APAC Intravitreal Injectable Sales by Region (2017-2022)
6.1.2 APAC Intravitreal Injectable Revenue by Region (2017-2022)
6.2 APAC Intravitreal Injectable Sales by Drug
6.3 APAC Intravitreal Injectable Sales by Disease
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Intravitreal Injectable by Country
7.1.1 Europe Intravitreal Injectable Sales by Country (2017-2022)
7.1.2 Europe Intravitreal Injectable Revenue by Country (2017-2022)
7.2 Europe Intravitreal Injectable Sales by Drug
7.3 Europe Intravitreal Injectable Sales by Disease
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Intravitreal Injectable by Country
8.1.1 Middle East & Africa Intravitreal Injectable Sales by Country (2017-2022)
8.1.2 Middle East & Africa Intravitreal Injectable Revenue by Country (2017-2022)
8.2 Middle East & Africa Intravitreal Injectable Sales by Drug
8.3 Middle East & Africa Intravitreal Injectable Sales by Disease
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intravitreal Injectable
10.3 Manufacturing Process Analysis of Intravitreal Injectable
10.4 Industry Chain Structure of Intravitreal Injectable
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intravitreal Injectable Distributors
11.3 Intravitreal Injectable Customer
12 World Forecast Review for Intravitreal Injectable by Geographic Region
12.1 Global Intravitreal Injectable Market Size Forecast by Region
12.1.1 Global Intravitreal Injectable Forecast by Region (2023-2028)
12.1.2 Global Intravitreal Injectable Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Intravitreal Injectable Forecast by Drug
12.7 Global Intravitreal Injectable Forecast by Disease
13 Key Players Analysis
13.1 Regeneron Pharmaceuticals (Eylea)
13.1.1 Regeneron Pharmaceuticals (Eylea) Company Information
13.1.2 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product Offered
13.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Regeneron Pharmaceuticals (Eylea) Main Business Overview
13.1.5 Regeneron Pharmaceuticals (Eylea) Latest Developments
13.2 Allergan
13.2.1 Allergan Company Information
13.2.2 Allergan Intravitreal Injectable Product Offered
13.2.3 Allergan Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Allergan Main Business Overview
13.2.5 Allergan Latest Developments
13.3 EyePoint Pharmaceuticals
13.3.1 EyePoint Pharmaceuticals Company Information
13.3.2 EyePoint Pharmaceuticals Intravitreal Injectable Product Offered
13.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 EyePoint Pharmaceuticals Main Business Overview
13.3.5 EyePoint Pharmaceuticals Latest Developments
13.4 Genentech
13.4.1 Genentech Company Information
13.4.2 Genentech Intravitreal Injectable Product Offered
13.4.3 Genentech Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Genentech Main Business Overview
13.4.5 Genentech Latest Developments
13.5 Kanghong Pharmaceutical
13.5.1 Kanghong Pharmaceutical Company Information
13.5.2 Kanghong Pharmaceutical Intravitreal Injectable Product Offered
13.5.3 Kanghong Pharmaceutical Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Kanghong Pharmaceutical Main Business Overview
13.5.5 Kanghong Pharmaceutical Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Intravitreal Injectable Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Intravitreal Injectable Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Anti-VEGF
Table 4. Major Players of Steroids
Table 5. Major Players of Others
Table 6. Global Intravitreal Injectable Sales by Drug (2017-2022) & (K Units)
Table 7. Global Intravitreal Injectable Sales Market Share by Drug (2017-2022)
Table 8. Global Intravitreal Injectable Revenue by Drug (2017-2022) & ($ million)
Table 9. Global Intravitreal Injectable Revenue Market Share by Drug (2017-2022)
Table 10. Global Intravitreal Injectable Sale Price by Drug (2017-2022) & (US$/Unit)
Table 11. Global Intravitreal Injectable Sales by Disease (2017-2022) & (K Units)
Table 12. Global Intravitreal Injectable Sales Market Share by Disease (2017-2022)
Table 13. Global Intravitreal Injectable Revenue by Disease (2017-2022)
Table 14. Global Intravitreal Injectable Revenue Market Share by Disease (2017-2022)
Table 15. Global Intravitreal Injectable Sale Price by Disease (2017-2022) & (US$/Unit)
Table 16. Global Intravitreal Injectable Sales by Company (2020-2022) & (K Units)
Table 17. Global Intravitreal Injectable Sales Market Share by Company (2020-2022)
Table 18. Global Intravitreal Injectable Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Intravitreal Injectable Revenue Market Share by Company (2020-2022)
Table 20. Global Intravitreal Injectable Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Intravitreal Injectable Producing Area Distribution and Sales Area
Table 22. Players Intravitreal Injectable Products Offered
Table 23. Intravitreal Injectable Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Intravitreal Injectable Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Intravitreal Injectable Sales Market Share Geographic Region (2017-2022)
Table 28. Global Intravitreal Injectable Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Intravitreal Injectable Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Intravitreal Injectable Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Intravitreal Injectable Sales Market Share by Country/Region (2017-2022)
Table 32. Global Intravitreal Injectable Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Intravitreal Injectable Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Intravitreal Injectable Sales by Country (2017-2022) & (K Units)
Table 35. Americas Intravitreal Injectable Sales Market Share by Country (2017-2022)
Table 36. Americas Intravitreal Injectable Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Intravitreal Injectable Revenue Market Share by Country (2017-2022)
Table 38. Americas Intravitreal Injectable Sales by Type (2017-2022) & (K Units)
Table 39. Americas Intravitreal Injectable Sales Market Share by Drug (2017-2022)
Table 40. Americas Intravitreal Injectable Sales by Disease (2017-2022) & (K Units)
Table 41. Americas Intravitreal Injectable Sales Market Share by Disease (2017-2022)
Table 42. APAC Intravitreal Injectable Sales by Region (2017-2022) & (K Units)
Table 43. APAC Intravitreal Injectable Sales Market Share by Region (2017-2022)
Table 44. APAC Intravitreal Injectable Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Intravitreal Injectable Revenue Market Share by Region (2017-2022)
Table 46. APAC Intravitreal Injectable Sales by Drug (2017-2022) & (K Units)
Table 47. APAC Intravitreal Injectable Sales Market Share by Drug (2017-2022)
Table 48. APAC Intravitreal Injectable Sales by Disease (2017-2022) & (K Units)
Table 49. APAC Intravitreal Injectable Sales Market Share by Disease (2017-2022)
Table 50. Europe Intravitreal Injectable Sales by Country (2017-2022) & (K Units)
Table 51. Europe Intravitreal Injectable Sales Market Share by Country (2017-2022)
Table 52. Europe Intravitreal Injectable Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Intravitreal Injectable Revenue Market Share by Country (2017-2022)
Table 54. Europe Intravitreal Injectable Sales by Type (2017-2022) & (K Units)
Table 55. Europe Intravitreal Injectable Sales Market Share by Drug (2017-2022)
Table 56. Europe Intravitreal Injectable Sales by Disease (2017-2022) & (K Units)
Table 57. Europe Intravitreal Injectable Sales Market Share by Disease (2017-2022)
Table 58. Middle East & Africa Intravitreal Injectable Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Intravitreal Injectable Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Intravitreal Injectable Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Intravitreal Injectable Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Intravitreal Injectable Sales by Drug (2017-2022) & (K Units)
Table 63. Middle East & Africa Intravitreal Injectable Sales Market Share by Drug (2017-2022)
Table 64. Middle East & Africa Intravitreal Injectable Sales by Disease (2017-2022) & (K Units)
Table 65. Middle East & Africa Intravitreal Injectable Sales Market Share by Disease (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Intravitreal Injectable
Table 67. Key Market Challenges & Risks of Intravitreal Injectable
Table 68. Key Industry Trends of Intravitreal Injectable
Table 69. Intravitreal Injectable Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Intravitreal Injectable Distributors List
Table 72. Intravitreal Injectable Customer List
Table 73. Global Intravitreal Injectable Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Intravitreal Injectable Sales Market Forecast by Region
Table 75. Global Intravitreal Injectable Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Intravitreal Injectable Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Intravitreal Injectable Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Intravitreal Injectable Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Intravitreal Injectable Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Intravitreal Injectable Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Intravitreal Injectable Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Intravitreal Injectable Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Intravitreal Injectable Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Intravitreal Injectable Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Intravitreal Injectable Sales Forecast by Drug (2023-2028) & (K Units)
Table 86. Global Intravitreal Injectable Sales Market Share Forecast by Drug (2023-2028)
Table 87. Global Intravitreal Injectable Revenue Forecast by Drug (2023-2028) & ($ Millions)
Table 88. Global Intravitreal Injectable Revenue Market Share Forecast by Drug (2023-2028)
Table 89. Global Intravitreal Injectable Sales Forecast by Disease (2023-2028) & (K Units)
Table 90. Global Intravitreal Injectable Sales Market Share Forecast by Disease (2023-2028)
Table 91. Global Intravitreal Injectable Revenue Forecast by Disease (2023-2028) & ($ Millions)
Table 92. Global Intravitreal Injectable Revenue Market Share Forecast by Disease (2023-2028)
Table 93. Regeneron Pharmaceuticals (Eylea) Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors
Table 94. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product Offered
Table 95. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Regeneron Pharmaceuticals (Eylea) Main Business
Table 97. Regeneron Pharmaceuticals (Eylea) Latest Developments
Table 98. Allergan Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors
Table 99. Allergan Intravitreal Injectable Product Offered
Table 100. Allergan Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Allergan Main Business
Table 102. Allergan Latest Developments
Table 103. EyePoint Pharmaceuticals Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors
Table 104. EyePoint Pharmaceuticals Intravitreal Injectable Product Offered
Table 105. EyePoint Pharmaceuticals Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. EyePoint Pharmaceuticals Main Business
Table 107. EyePoint Pharmaceuticals Latest Developments
Table 108. Genentech Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors
Table 109. Genentech Intravitreal Injectable Product Offered
Table 110. Genentech Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Genentech Main Business
Table 112. Genentech Latest Developments
Table 113. Kanghong Pharmaceutical Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors
Table 114. Kanghong Pharmaceutical Intravitreal Injectable Product Offered
Table 115. Kanghong Pharmaceutical Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Kanghong Pharmaceutical Main Business
Table 117. Kanghong Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Intravitreal Injectable
Figure 2. Intravitreal Injectable Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intravitreal Injectable Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Intravitreal Injectable Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Intravitreal Injectable Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Anti-VEGF
Figure 10. Product Picture of Steroids
Figure 11. Product Picture of Others
Figure 12. Global Intravitreal Injectable Sales Market Share by Drug in 2021
Figure 13. Global Intravitreal Injectable Revenue Market Share by Drug (2017-2022)
Figure 14. Intravitreal Injectable Consumed in Macular Degeneration
Figure 15. Global Intravitreal Injectable Market: Macular Degeneration (2017-2022) & (K Units)
Figure 16. Intravitreal Injectable Consumed in Macular Edema
Figure 17. Global Intravitreal Injectable Market: Macular Edema (2017-2022) & (K Units)
Figure 18. Intravitreal Injectable Consumed in Uveitis
Figure 19. Global Intravitreal Injectable Market: Uveitis (2017-2022) & (K Units)
Figure 20. Intravitreal Injectable Consumed in Retinal Vein Occlusion
Figure 21. Global Intravitreal Injectable Market: Retinal Vein Occlusion (2017-2022) & (K Units)
Figure 22. Intravitreal Injectable Consumed in Others
Figure 23. Global Intravitreal Injectable Market: Others (2017-2022) & (K Units)
Figure 24. Global Intravitreal Injectable Sales Market Share by Disease (2017-2022)
Figure 25. Global Intravitreal Injectable Revenue Market Share by Disease in 2021
Figure 26. Intravitreal Injectable Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Intravitreal Injectable Revenue Market Share by Company in 2021
Figure 28. Global Intravitreal Injectable Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Intravitreal Injectable Revenue Market Share by Geographic Region in 2021
Figure 30. Global Intravitreal Injectable Sales Market Share by Region (2017-2022)
Figure 31. Global Intravitreal Injectable Revenue Market Share by Country/Region in 2021
Figure 32. Americas Intravitreal Injectable Sales 2017-2022 (K Units)
Figure 33. Americas Intravitreal Injectable Revenue 2017-2022 ($ Millions)
Figure 34. APAC Intravitreal Injectable Sales 2017-2022 (K Units)
Figure 35. APAC Intravitreal Injectable Revenue 2017-2022 ($ Millions)
Figure 36. Europe Intravitreal Injectable Sales 2017-2022 (K Units)
Figure 37. Europe Intravitreal Injectable Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Intravitreal Injectable Sales 2017-2022 (K Units)
Figure 39. Middle East & Africa Intravitreal Injectable Revenue 2017-2022 ($ Millions)
Figure 40. Americas Intravitreal Injectable Sales Market Share by Country in 2021
Figure 41. Americas Intravitreal Injectable Revenue Market Share by Country in 2021
Figure 42. United States Intravitreal Injectable Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Intravitreal Injectable Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Intravitreal Injectable Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Intravitreal Injectable Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Intravitreal Injectable Sales Market Share by Region in 2021
Figure 47. APAC Intravitreal Injectable Revenue Market Share by Regions in 2021
Figure 48. China Intravitreal Injectable Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Intravitreal Injectable Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Intravitreal Injectable Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Intravitreal Injectable Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Intravitreal Injectable Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Intravitreal Injectable Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Intravitreal Injectable Sales Market Share by Country in 2021
Figure 55. Europe Intravitreal Injectable Revenue Market Share by Country in 2021
Figure 56. Germany Intravitreal Injectable Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Intravitreal Injectable Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Intravitreal Injectable Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Intravitreal Injectable Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Intravitreal Injectable Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Intravitreal Injectable Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Intravitreal Injectable Revenue Market Share by Country in 2021
Figure 63. Egypt Intravitreal Injectable Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Intravitreal Injectable Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Intravitreal Injectable Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Intravitreal Injectable Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Intravitreal Injectable Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Intravitreal Injectable in 2021
Figure 69. Manufacturing Process Analysis of Intravitreal Injectable
Figure 70. Industry Chain Structure of Intravitreal Injectable
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
